ZAP70 Activation Compensates for Loss of Class IA PI3K Isoforms Through Activation of the JAK-STAT3 Pathway

Melike Demir1, Onur Cizmecioglu1

  • 1Department of Molecular Biology and Genetics, Bilkent University, Ankara, Turkey.

Abstract

Insights

Activated zeta chain of T-cell receptor-associated protein kinase 70 (ZAP70) drives cancer cell proliferation and resistance to phosphatidylinositol 3-kinase (PI3K) inhibitors by activating the JAK/STAT3 pathway.

Area of Science:

  • Cellular signaling and cancer biology
  • Molecular mechanisms of cancer resistance

Background:

  • The phosphatidylinositol 3-kinase (PI3K) pathway is crucial for cell proliferation and frequently deregulated in cancer.
  • Understanding resistance mechanisms to PI3K inhibition is vital for effective cancer therapy.

Purpose of the Study:

  • To identify tyrosine kinases contributing to resistance against PI3K silencing and inhibition.
  • To elucidate the role of ZAP70 in PI3K inhibitor resistance and cellular transformation.

Main Methods:

  • Utilized specific inhibitors (BYL719, KIN193) and genetic knock-out to mimic p110α/β inactivation.
  • Assessed cell viability using crystal violet staining and cellular transformation via soft-agar growth assays.

Main Results:

  • Activated zeta chain of T-cell receptor-associated protein kinase 70 (ZAP70) conferred resistance to PI3K inhibition.
  • ZAP70 activated the Janus kinase/signal transducer and activator of transcription 3 (JAK/STAT3) axis, mediating resistance.
  • Activated ZAP70 demonstrated significant transforming capability, promoting malignant phenotypes and acting as a potential tumor-initiating factor.

Conclusions:

  • ZAP70 is implicated as a driver of proliferation and transformation in untransformed cells.
  • ZAP70 plays a key role in mediating cancer cell resistance to PI3K inhibitors.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.1K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.7K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.3K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K